Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "S01EE" (39)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Latanoprost (S01EE01) 15 products
WHO-DDD
DrugBank.ca
IP
CI
Xalatan
2.5 ml
10.70
20.50
10 %
Viatris Pharma GmbH
B / SL / SO
FB
G
IP
CI
Xalatan
3 x 2.5 ml
31.55
52.65
10 %
Viatris Pharma GmbH
B / SL / SO
FB
G
IP
CI
CM
Latanoprost Viatris
2.5 ml
10.13
19.85
10 %
Latanoprostum 50 mcg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Latanoprost Viatris
3 x 2.5 ml
29.79
50.65
10 %
Latanoprostum 50 mcg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Latano-Vision
2.5 ml
9.45
19.05
10 %
Eye drops: Latanoprostum 50 µg/ml
OmniVision AG
B / SL / SG
FB
G
IP
CI
Latano-Vision
3 x 2.5 ml
27.60
48.15
10 %
Eye drops: Latanoprostum 50 µg/ml
OmniVision AG
B / SL / SG
FB
G
IP
CI
Latanoprost-Mepha
2.5 ml
9.96
19.65
10 %
Eye drops: Latanoprostum 50 µg/ml
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Latanoprost-Mepha
3 x 2.5 ml
29.79
50.65
10 %
Eye drops: Latanoprostum 50 µg/ml
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Monoprost
30 unidose(s)
13.30
27.60
10 %
Augentropfen SDU: Latanoprostum 50 µg/ml
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Monoprost
30
13.30
27.60
10 %
Augentropfen SDU: Latanoprostum 50 µg/ml
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Monoprost
90 unidose(s)
37.90
59.95
10 %
Augentropfen SDU: Latanoprostum 50 µg/ml
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Monoprost
90
37.90
59.95
10 %
Augentropfen SDU: Latanoprostum 50 µg/ml
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Latanoprost-Mepha
6 x 2.5 ml
PR
PR
k.A.
Eye drops: Latanoprostum 50 µg/ml
Mepha Pharma AG
B
FB
G
IP
CI
Latanomed
2.5 ml
9.84
19.50
k.A.
Dermapharm AG
B
FB
G
IP
CI
Latanomed
3 x 2.5 ml
28.83
49.50
k.A.
Dermapharm AG
B
FB
G
Bimatoprost (S01EE03) 7 products
WHO-DDD
DrugBank.ca
Elymbus 0.1 mg/g
30 x 0.3 g
PR
PR
k.A.
THEA Pharma S.A.
B
FB
G
Elymbus 0.1 mg/g
90 x 0.3 g
PR
PR
k.A.
THEA Pharma S.A.
B
FB
G
IP
CI
Lumigan, 0.1 mg/ml
3 ml
14.66
29.15
10 %
Eye drops: Bimatoprostum
AbbVie AG
B / SL
FB
G
IP
CI
Lumigan, 0.1 mg/ml
3 x 3 ml
41.16
63.70
10 %
Eye drops: Bimatoprostum
AbbVie AG
B / SL
FB
G
IP
CI
Lumigan 0,3 mg/ml Unit
Dose
30 x 0.4 ml
17.82
36.90
10 %
Eye drops: Bimatoprostum
AbbVie AG
B / SL
FB
G
IP
CI
Lumigan 0,3 mg/ml Unit
Dose
90 x 0.4 ml
50.80
74.80
10 %
Eye drops: Bimatoprostum
AbbVie AG
B / SL
FB
G
IP
CI
Bimatoprost Labatec 0.3
mg/ml
3 ml
PR
PR
k.A.
collyre en solution: Bimatoprostum
Labatec Pharma SA
B
FB
G
Travoprost (S01EE04) 8 products
WHO-DDD
DrugBank.ca
Travo-Vision SDU 40 ug / ml
30 x 0.2 ml
PR
PR
k.A.
Augentropfen im Einzeldosisbehältnis: Travoprostum
OmniVision AG
B
FB
G
Travo-Vision SDU 40 ug / ml
90 x 0.2 ml
PR
PR
k.A.
Augentropfen im Einzeldosisbehältnis: Travoprostum
OmniVision AG
B
FB
G
IP
CI
Travatan
2.5 ml
11.02
25.00
20 %
Eye drops: Travoprostum 40 µg/ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Travatan
3 x 2.5 ml
31.44
52.55
20 %
Eye drops: Travoprostum 40 µg/ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Travo-Vision 40mcg/ml
2.5 ml
9.93
19.60
10 %
Eye drops: Travoprostum 40 µg
OmniVision AG
B / SL / SG
FB
G
IP
CI
Travo-Vision 40mcg/ml
3 x 2.5 ml
28.30
48.95
10 %
Eye drops: Travoprostum 40 µg
OmniVision AG
●
B / SL / SG
FB
G
IP
CI
Travoprost-Mepha
2.5 ml
9.93
19.60
10 %
Eye drops: Travoprostum 40 µg/ml
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
CI
Travoprost-Mepha
3 x 2.5 ml
28.30
48.95
10 %
Eye drops: Travoprostum 40 µg/ml
Mepha Pharma AG
B / SL / SG
FB
G
Tafluprost (S01EE05) 7 products
WHO-DDD
DrugBank.ca
IP
CI
Saflutan
3 ml
18.22
37.35
10 %
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B / SL
FB
G
IP
CI
Saflutan
30 unidose(s)
19.53
38.85
10 %
unidose de collyre: Tafluprostum 15 µg/ml
Santen SA
B / SL
FB
G
IP
CI
Saflutan
5 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
IP
CI
Saflutan
7 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
IP
CI
Saflutan
3 x 3 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
Tafluprost Santen 15 mcg / ml
30 x 0.3 ml
PR
PR
k.A.
unidose de collyre: Tafluprostum 15 µg/ml
Santen SA
B
FB
G
Tafluprost Santen 15 mcg / ml
90 x 0.3 ml
PR
PR
k.A.
unidose de collyre: Tafluprostum 15 µg/ml
Santen SA
B
FB
G
Latanoprost and Netarsudil (S01EE51) 2 products
WHO-DDD
IP
CI
Roclanda
2.5 ml
PR
PR
k.A.
collyre en solution: 2 Active Agents
Santen SA
B
FB
G
IP
CI
Roclanda
3 x 2.5 ml
PR
PR
k.A.
collyre en solution: 2 Active Agents
Santen SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
